Physician profile
Patrick L Murphy
NPI 1336130541
$8,226.43
in general payments reported to CMS, 2019-2025
40 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,526 · 2020: $1,092 · 2021: $1,487 · 2022: $1,287 · 2023: $1,047 · 2024: $1,110 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,833.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $1,552.92 | 2019-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $1,123.66 | 2019-2025 | Watchman Flx, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $1,117.02 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $603.90 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $557.83 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $492.07 | 2019-2022 | |
| Medtronic, INC. | $340.50 | 2021-2025 | Onyx Frontier, Symplicity G3 |
| Novo Nordisk INC | $334.41 | 2019-2025 | Ozempic, Rybelsus |
| Medtronic Vascular, INC. | $308.58 | 2020 | |
| Lundbeck LLC | $198.22 | 2024-2025 | Rexulti |
| Inari Medical, INC. | $187.97 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $175.24 | 2019-2022 | |
| Ge Healthcare | $144.31 | 2024 | |
| Abiomed | $132.69 | 2024 | Impella |
| Biotronik INC. | $111.84 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.